These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 22926059)
1. CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells. Naito M; Hainz U; Burkhardt UE; Fu B; Ahove D; Stevenson KE; Rajasagi M; Zhu B; Alonso A; Witten E; Matsuoka K; Neuberg D; Duke-Cohan JS; Wu CJ; Freeman GJ Cancer Immunol Immunother; 2013 Feb; 62(2):347-57. PubMed ID: 22926059 [TBL] [Abstract][Full Text] [Related]
2. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC. Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385 [TBL] [Abstract][Full Text] [Related]
3. A multimerized form of recombinant human CD40 ligand supports long-term activation and proliferation of B cells. Garcia-Marquez MA; Shimabukuro-Vornhagen A; Theurich S; Kochanek M; Weber T; Wennhold K; Dauben A; Dzionek A; Reinhard C; von Bergwelt-Baildon M Cytotherapy; 2014 Nov; 16(11):1537-1544. PubMed ID: 25287602 [TBL] [Abstract][Full Text] [Related]
4. A membrane-bound form of IL-4 enhances proliferation and antigen presentation of CD40-activated human B cells. Park JY; Yoon SH; Kim EK; Yun SO; Park MY; Sohn HJ; Kim TG Immunol Lett; 2008 Feb; 116(1):33-40. PubMed ID: 18096249 [TBL] [Abstract][Full Text] [Related]
5. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589 [TBL] [Abstract][Full Text] [Related]
6. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes. Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056 [TBL] [Abstract][Full Text] [Related]
7. Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. Mayr C; Bund D; Schlee M; Moosmann A; Kofler DM; Hallek M; Wendtner CM Blood; 2005 Feb; 105(4):1566-73. PubMed ID: 15471955 [TBL] [Abstract][Full Text] [Related]
8. CD40 stimulation induces differentiation of acute lymphoblastic leukemia cells into dendritic cells. Luczyński W; Stasiak-Barmuta A; Iłendo E; Krawczuk-Rybak M; Malinowska I; Mitura-Lesiuk M; Parfieńczyk A; Szymański M Acta Biochim Pol; 2006; 53(2):377-82. PubMed ID: 16733557 [TBL] [Abstract][Full Text] [Related]
9. Generation of potent T(h)1 responses from patients with lymphoid malignancies after differentiation of B lymphocytes into dendritic-like cells. Mohty M; Isnardon D; Charbonnier A; Lafage-Pochitaloff M; Merlin M; Sainty D; Olive D; Gaugler B Int Immunol; 2002 Jul; 14(7):741-50. PubMed ID: 12096033 [TBL] [Abstract][Full Text] [Related]
10. Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells. Mayr C; Kofler DM; Büning H; Bund D; Hallek M; Wendtner CM Blood; 2005 Nov; 106(9):3223-6. PubMed ID: 16014560 [TBL] [Abstract][Full Text] [Related]
11. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions. Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330 [TBL] [Abstract][Full Text] [Related]
12. Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells. Parente-Ribes A; Skånland SS; Bürgler S; Os A; Wang D; Bogen B; Tjønnfjord GE; Taskén K; Munthe LA Haematologica; 2016 Feb; 101(2):e59-62. PubMed ID: 26589914 [No Abstract] [Full Text] [Related]
14. CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides. Ahmadi T; Flies A; Efebera Y; Sherr DH Immunology; 2008 May; 124(1):129-40. PubMed ID: 18067555 [TBL] [Abstract][Full Text] [Related]
15. Transgenic expression of CD40 ligand produces an in vivo antitumor immune response against both CD40(+) and CD40(-) plasmacytoma cells. Dotti G; Savoldo B; Yotnda P; Rill D; Brenner MK Blood; 2002 Jul; 100(1):200-7. PubMed ID: 12070028 [TBL] [Abstract][Full Text] [Related]
16. CD40L is transferred to antigen-presenting B cells during delivery of T-cell help. Gardell JL; Parker DC Eur J Immunol; 2017 Jan; 47(1):41-50. PubMed ID: 27753080 [TBL] [Abstract][Full Text] [Related]
17. Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application. von Bergwelt-Baildon MS; Vonderheide RH; Maecker B; Hirano N; Anderson KS; Butler MO; Xia Z; Zeng WY; Wucherpfennig KW; Nadler LM; Schultze JL Blood; 2002 May; 99(9):3319-25. PubMed ID: 11964299 [TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity. Schattner EJ; Mascarenhas J; Reyfman I; Koshy M; Woo C; Friedman SM; Crow MK Blood; 1998 Apr; 91(8):2689-97. PubMed ID: 9531577 [TBL] [Abstract][Full Text] [Related]
19. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes. Takahashi S; Rousseau RF; Yotnda P; Mei Z; Dotti G; Rill D; Hurwitz R; Marini F; Andreeff M; Brenner MK Hum Gene Ther; 2001 Apr; 12(6):659-70. PubMed ID: 11426465 [TBL] [Abstract][Full Text] [Related]
20. Potential immaturity of the T-cell and antigen-presenting cell interaction in cord blood with particular emphasis on the CD40-CD40 ligand costimulatory pathway. Han P; McDonald T; Hodge G Immunology; 2004 Sep; 113(1):26-34. PubMed ID: 15312133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]